ADs body raps GSK

An advertising watchdog has upheld a complaint against GlaxoSmithKline for claiming that its NiQuitin CQ Lozenges could triple' the chances of quitting smoking. The Advertising Standards Authority ruled that GSK could not substantiate the claim,...

 

Already have an account? Sign in here

You’ve used up your article allowance

Sign up to read more stories for free

Register now